LIU GENE sold $254K of TEAM
LIU GENE (Chief Accounting Officer) sold 1,552 shares of Atlassian Corp (TEAM) at an average of $163.95 ($162.38–$167.29, $0.25M total) across 7 trades over 2026-08-13 to 2026-08-14 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure updates the record of insider activity and may influence short-term sentiment, but it does not introduce new company fundamentals.
Market read
Traders may note the insider sale size ($254k) and timing, but the 10b5-1 structure suggests limited informational content.
What to watch
The article provides only the sale details; it does not include any concurrent buys, company guidance, or operational developments that would make the transaction more informative.
Background
The article is a SEC Form 4 insider transaction for Atlassian (TEAM) by Chief Accounting Officer Liu Gene.
Ticker impact
Atlassian Form 4 shows CFO Liu Gene sold $254,449 of TEAM shares across 7 trades under a pre-arranged 10b5-1 plan.
Likely limited, with any impact confined to short-term sentiment rather than a sustained repricing.
The filing is a Form 4 insider transaction with an explicit 10b5-1 plan, indicating pre-scheduled selling rather than new negative information.
Market effects
Minimal; insider 10b5-1 selling does not signal sector-wide fundamentals.
None indicated.
None indicated.
Counterpoint
Even with 10b5-1, repeated insider selling can still be interpreted by some traders as confidence erosion, especially if paired with other negative signals not present here.
Key entities
- issuerAtlassian Corp
Subject of the Form 4 insider transaction; ticker TEAM.
- insiderLiu Gene
Chief Accounting Officer who sold shares under a pre-arranged 10b5-1 plan.
